Did David Perdue buy Cardlytics stock?

Common questions

Did David Perdue buy Cardlytics stock?

Yes. David Perdue disclosed 2 purchases and 1 sale of Cardlytics (CDLX) stock between Jul 18, 2017 and Jan 23, 2020, in STOCK Act reports. Added together, the disclosed purchases come to $2.0M-$10.0M and the disclosed sales to $1.0M-$5.0M.

How big were David Perdue's Cardlytics trades?

STOCK Act reports give a range for each trade, such as $1M-$5M, never an exact amount. Added together, the disclosed purchases come to $2.0M-$10.0M and the disclosed sales to $1.0M-$5.0M.

Did David Perdue make these Cardlytics trades personally?

Not always. The STOCK Act requires members to report trades by themselves, a spouse and dependent children. The owner column of each linked filing says whose trade it was.

Does David Perdue still own Cardlytics stock?

This page lists reported trades, not holdings. A purchase can have been sold since, and the filings shown do not say what is held today.

When did David Perdue report these trades?

The latest filing is dated Feb 3, 2020. The STOCK Act gives members of Congress 45 days to report a trade, so a filing can trail the trade by weeks. Every row shows both dates.

Where does this data come from?

From periodic transaction reports filed under the STOCK Act with the Secretary of the Senate. Every trade links to the original filing.